Weekly Intelligence · 25 articles

Vet Industry Intel: Aug 23 – Aug 29, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Acquisitions & M&A (3) Funding & Investment (2) Regulatory & Policy (13) Products & Technology (7)

Acquisitions & M&A

Aug 25, 2026 [9/10] PR Newswire

BiomEdit Acquires Folium Science Technology and Pipeline Assets to Expand Programmable Veterinary Biologics Capabilities

BiomEdit announced the acquisition of Folium Science's technology and pipeline assets to enhance its programmable veterinary biologics capabilities.

BiomEdit · Folium Science · PR Newswire

Aug 25, 2026 [9/10] citybiz

BiomEdit Acquires Folium Science Assets to Expand Veterinary Biologics Pipeline

BiomEdit has acquired assets from Folium Science to broaden its veterinary biologics pipeline.

BiomEdit · Folium Science · citybiz

Aug 26, 2026 [8/10] Patch

Private Equity Pet Hospital Investors Expand In Contra Costa

Private equity investors are expanding their pet hospital portfolio in Contra Costa County, California.

Private Equity Pet Hospital Investors | CA

Funding & Investment

Aug 25, 2026 [9/10] Kalkine Media

Optiscan Imaging Secures $17.75M, Files First FDA Dossier, and Launches InSpecta™ in FY2026 Annual Report

Optiscan Imaging raised $17.75 million, filed its first FDA dossier, and announced the launch of its InSpecta™ product in FY2026.

Optiscan Imaging · FDA

Aug 24, 2026 [9/10] Kalkine

Optiscan Imaging Raises $17.75m, Submits First FDA Dossier in FY2026 Annual Report

Optiscan Imaging secured $17.75 million in funding and submitted its first FDA dossier for FY2026, marking a significant milestone for the company.

Optiscan Imaging · FDA

Regulatory & Policy

Aug 27, 2026 [9/10] Pet Age

Cronus Pharma Unveils FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

Cronus Pharma announced that its bioequivalent Robenacoxib injection has received FDA approval for veterinary use.

Cronus Pharma · FDA

Aug 25, 2026 [9/10] GlobeNewswire

Endovia Health Sciences, formerly Splash Beverage, Achieves

Endovia Health Sciences, formerly Splash Beverage, has achieved FDA approval for a new veterinary product.

Endovia Health Sciences · FDA

Aug 25, 2026 [9/10] DVM360

FDA approves new vial size for Nocita

The U.S. Food and Drug Administration approved a new vial size for the veterinary drug Nocita, as reported by DVM360.

Nocita · DVM360

Aug 26, 2026 [9/10] TipRanks

Argent BioPharma Secures FDA-CVM INAD for CannEpil Veterinary Cancer-Pain Program

Argent BioPharma has obtained FDA-CVM Investigational New Animal Drug approval for its CannEpil Veterinary Cancer-Pain Program.

Argent BioPharma · FDA-CVM

Aug 24, 2026 [9/10] Yahoo Finance

Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business?

Zoetis received emergency authorization from the FDA for its product Simparica Trio, potentially impacting its U.S. business.

Zoetis

Aug 25, 2026 [9/10] simplywall.st

The Bull Case For Zoetis (ZTS) Could Change Following FDA Emergency Use Authorization For Simparica Trio

Zoetis received FDA emergency use authorization for its parasite control product Simparica Trio, potentially impacting its market position.

Zoetis · FDA · simplywall.st | NJ

Aug 25, 2026 [9/10] GlobeNewswire

Endovia Health Sciences, formerly Splash Beverage, Achieves

Endovia Health Sciences, formerly Splash Beverage, has achieved regulatory approval from the FDA's Center for Veterinary Medicine.

Endovia Health Sciences · FDA

Aug 28, 2026 [9/10] AGDAILY

FDA authorizes generic ivermectin as U.S. screwworm cases reach 47

The U.S. Food and Drug Administration authorized the use of generic ivermectin to treat screwworm infestations, following an increase to 47 reported cases.

FDA · generic ivermectin

Aug 26, 2026 [9/10] Kalkine

Argent BioPharma Secures FDA-CVM INAD File No. 14145 for CannEpil® Veterinary Programme

Argent BioPharma filed an INAD with the FDA for its CannEpil veterinary program, marking a regulatory step toward approval.

Argent BioPharma · FDA

Aug 29, 2026 [9/10] bovinevetonline.com

FDA Issues First Generic Injectable Cattle Dewormer EUA for Prevention of Screwworm

The U.S. Food and Drug Administration granted an Emergency Use Authorization for the first generic injectable cattle dewormer to prevent screwworm infestation.

FDA

Aug 28, 2026 [9/10] thecattlesite.com

FDA approves generic ivermectin drug for screwworm prevention

The U.S. Food and Drug Administration approved a generic ivermectin drug for preventing screwworm infestations in livestock.

FDA · generic ivermectin

Aug 24, 2026 [9/10] facebook.com

Certain Fromm Family Foods canned dog foods are under recall as they may contain metal. Here's what to know. See link below ⬇️ 📸 U.S. Food and Drug Administration

The U.S. Food and Drug Administration has recalled certain canned dog foods from Fromm Family Foods due to potential metal contamination.

U.S. Food and Drug Administration · Fromm Family Foods

Aug 27, 2026 [9/10] DVM360

FDA approves emergency use of generic ivermectin to prevent New World screwworm in cattle

The U.S. Food and Drug Administration approved emergency use authorization for generic ivermectin to prevent New World screwworm infestation in cattle.

FDA

Products & Technology

Aug 26, 2026 [9/10] BioBuzz

Cronus Pharma Launches First FDA-Approved Generic Robenacoxib Injection for Pain Control in Dogs and Cats

Cronus Pharma has launched the first FDA‑approved generic version of Robenacoxib injection for pain control in dogs and cats.

Cronus Pharma · FDA · BioBuzz

Aug 26, 2026 [9/10] New Castle News

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

Cronus Pharma announced the launch of its first FDA‑approved bioequivalent robenacoxib injection for veterinary use.

Cronus Pharma · FDA · New Castle News | DE

Aug 24, 2026 [9/10] Yahoo Finance UK

Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business?

Zoetis received emergency authorization from the FDA for its product Simparica Trio, a veterinary parasite control medication, potentially bolstering its U.S. business amid a slowdown.

Zoetis · FDA

Aug 27, 2026 [9/10] Indian Pharma Post

Cronus Pharma unveils FDA-approved generic Robenacoxib injection for veterinary use

Cronus Pharma announced that its generic Robenacoxib injection has received FDA approval for veterinary use.

Cronus Pharma · FDA

Aug 26, 2026 [9/10] FinancialContent

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

Cronus Pharma announced the launch of its first FDA‑approved bioequivalent robenacoxib injection for veterinary use.

Cronus Pharma · FDA · FinancialContent

Aug 27, 2026 [9/10]

Cronus Pharma launches first FDA-approved injection for veterinary use to control postoperative pain in dogs and cats - ROI-NJ

Cronus Pharma has launched its first FDA‑approved injection for controlling postoperative pain in dogs and cats.

Cronus Pharma · FDA | NJ

Aug 26, 2026 [9/10] BioSpace

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - August 26, 2026

Cronus Pharma has announced the launch of its first FDA‑approved bioequivalent robenacoxib injection for veterinary use, marking a new product addition to the veterinary analgesic market.

Cronus Pharma · FDA · BioSpace

Most-mentioned this week

Zoetis (1) · BiomEdit (1) · Private Equity Pet Hospital Investors (1)